awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38722972-A4FD9A94-823C-4A46-896A-7DF88F46E5F1
Q38722972-A4FD9A94-823C-4A46-896A-7DF88F46E5F1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38722972-A4FD9A94-823C-4A46-896A-7DF88F46E5F1
Cost Effectiveness of Pembrolizumab vs. Standard-of-Care Chemotherapy as First-Line Treatment for Metastatic NSCLC that Expresses High Levels of PD-L1 in the United States.
P2860
Q38722972-A4FD9A94-823C-4A46-896A-7DF88F46E5F1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38722972-A4FD9A94-823C-4A46-896A-7DF88F46E5F1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
47ebfb264f33242af89da942a117752428f112a1
P2860
Patient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death.